Australia's Healius jumps most in nearly 4 years as CEO exits amid strategic review

Healius

05/03/2024 02:37

(Updates)
    ** Shares of medical centre operator Healius  HLS.AX 
advance as much as 16% to A$1.31, their biggest intraday pct
gain since June 2020 
    ** Co says it has commenced a strategic review of its
structure and assets 
    ** Says CFO Paul Anderson will take over as CEO and managing
director, replacing Maxine Jaquet
    ** Shares touch their highest level since Feb. 27 
    ** Stock is the biggest pct gainer on the benchmark S&P/ASX
200 index  .AXJO  
    ** Analysts at Citi say a sale of co's imaging business is
the most likely scenario
        ** Citi adds a potential partial sale of the pathology
division might also be on the cards
    ** Stock down 31.2% this year, as of last close
    

 (Reporting by Roushni Nair and Rishav Chatterjee in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))